论文部分内容阅读
赛若金(SINOGEN),原名悦复能(REFERON),是北大未名生物工程集团与美国汉鼎亚太公司共同创办的深圳科兴生物制品有限公司生产的注射用冻干人α-1b型基因工程干扰素,该产品是世男上第一个采用中国健康人白细胞来源的干优素基因克隆和表达的基因工程药物,是我国“863”计划生物技术领域第一个实现产业化的产品,是卫生部批准生产的第一个基
SINOGEN, formerly known as REFERON, is a lyophilized human α-1b gene for injection manufactured by Shenzhen Kexing Bio-Products Co., Ltd., co-founded by Peking University Unidentified Bioengineering Group and American H & Q Asia Pacific Company Engineering interferon, which is the first genetically engineered drug that has been cloned and expressed by Chinese white blood cell healthy stem cells derived from Chinese white blood cells. It is the first industrialized product in the field of “863” plan biotechnology in China. Ministry of Health approved the production of the first base